Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
173
datasets available to search
ShareScore release 0.9.0
Dataset results
173 results for “Malignant pleural mesothelioma;”
S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery
ClinicalTrials.gov study NCT00243074. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma
ClinicalTrials.gov study NCT06037941. IPD Sharing: YES. Countries: 1. Publications: 0.
Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent
ClinicalTrials.gov study NCT02568449. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma
ClinicalTrials.gov study NCT02959463. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Window of Opportunity Study of VS-6063 (Defactinib) in Surgical Resectable Malignant Pleural Mesothelioma Participants
ClinicalTrials.gov study NCT02004028. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma
ClinicalTrials.gov study NCT01112293. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma
ClinicalTrials.gov study NCT04158141. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov study NCT02672033. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM)
ClinicalTrials.gov study NCT00604461. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma
ClinicalTrials.gov study NCT03436732. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov study NCT03710876. IPD Sharing: NO. Countries: 9. Publications: 0.
Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov study NCT04166734. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma
ClinicalTrials.gov study NCT03075527. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM)
ClinicalTrials.gov study NCT02357147. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy
ClinicalTrials.gov study NCT01085630. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity
ClinicalTrials.gov study NCT01024946. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Characterization by RNAseq of malignant pleural mesothelioma cell lines and their response to palbociclib
GEO Series GSE195568. Homo sapiens. 33 samples. Type: Expression profiling by high throughput sequencing.
PD-1 blockade mitigates surgery-induced immunosuppression and increases the efficacy of photodynamic therapy for malignant pleural mesothelioma
GEO Series GSE272176. Homo sapiens. 82 samples. Type: Expression profiling by high throughput sequencing.
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
GEO Series GSE29211. Homo sapiens. 131 samples. Type: Expression profiling by array; Genome variation profiling by SNP array; SNP genotyping by SNP array; Genome variation profiling by genome tiling array.
Inactivation of Bap1 Cooperates with Losses of Nf2 and Cdkn2a to Drive the Development of Pleural Malignant Mesothelioma in Conditional Mouse Models
GEO Series GSE131942. Mus musculus. 8 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.